Buckingham Strategic Partners Exact Sciences Corp Transaction History

Buckingham Strategic Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $16,848 - $26,017	527 Added 5.14%	10,788 $351,000
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $365,394 - $782,196	10,261 New	10,261 $404,000
Q1 2022 May 10, 2022	SELL	$57.56 - $82.54 $588,263 - $843,558	-10,220 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $740,950 - $1.03 Million	10,220 New	10,220 $794,000

667

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

Stay updated on Buckingham Strategic Partners with notifications on news.